Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. - Archive ouverte HAL Access content directly
Journal Articles Cancer Letters Year : 2008

Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.

(1) , (2) , (3) , (4) , (1)
1
2
3
4

Abstract

FTY720 is an immunomodulator that is phosphorylated in vivo and inhibits lymphocyte mobilization by targeting sphingosine 1-phospate receptors. At doses higher than required for immunomodulation, FTY720 inhibits tumor progression through an unknown mechanism. Here we show that FTY720-phosphate is a competitive inhibitor (Ki approximately 0.2microM) of autotaxin (ATX or NPP2), a nucleotide phosphodiesterase/pyrophosphatase (NPP) that enhances metastasis and angiogenesis and acts as a lysophospholipase D to produce the lipid mediator lysophosphatidic acid (LPA). FTY720-phosphate did no affect the activity of NPP1, the closest relative of ATX. After oral administration in mice, FTY720 (3mg/kg) significantly reduced plasma LPA levels. These results suggest that FTY720 may exert its anticancer effects, at least in part, by targeting the ATX-LPA axis.

Dates and versions

inserm-00409422 , version 1 (07-08-2009)

Identifiers

Cite

Laurens A. van Meeteren, Volker Brinkmann, Jean Sébastien Saulnier-Blache, Kevin R. Lynch, Wouter H. Moolenaar. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.. Cancer Letters, 2008, 266 (2), pp.203-8. ⟨10.1016/j.canlet.2008.02.052⟩. ⟨inserm-00409422⟩
25 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More